Abstract Stress and/or anxiety during pregnancy affect maternal and fetal well-being and can cause premature delivery and postnatal pathology in the child. Women suffering from phobias related to blood and injections are prone to high levels of stress, including anxiety and sometimes panic attacks, during pregnancy. Cortisol is amongst the mediators through which the neurohormonal expressions of maternal psychological factors may be transduced to the fetus. The aim of this study was to investigate whether pregnant women suffering from blood and injection phobia have raised cortisol levels or are characterized by unusual diurnal salivary cortisol profiles compared with healthy controls. The sample consisted of 110 pregnant women with blood and injection phobia and 110 pregnant healthy controls. Both groups provided morning and evening saliva samples in weeks 25 and 36 for the assay of cortisol. In gestational week 25, when blood was drawn for the mandatory blood testing, extra blood was taken to analyze corticotrophin-releasing factor, adrenocorticotropic hormone, and cortisol in serum. The diurnal decline in salivary cortisol as well as increased cortisol levels were observed during pregnancy. Pregnant women suffering from blood and injection phobia had a higher output of cortisol compared with women without the phobia (F=6.25, df=1, p=0.014), but no marked difference in the diurnal cortisol rhythm was found between groups. Our findings indicate that untreated blood and injection phobia during pregnancy increases cortisol concentrations. Blood and injection phobia is treatable, and cognitive behavioral therapy can be used. Women with blood and injection phobia during pregnancy therefore need to be recognized and offered treatment without delay in early pregnancy.
Introduction
There is ample evidence from both animal and human studies showing the importance of maternal psychological functioning during pregnancy regarding maternal and fetal well-being (Herbert et al. 2006; Seckl and Holmes 2007; Talge et al. 2007 ; van den Bergh et al. 2005; Weinstock 2001 ). Blood and injection phobia is categorized as an anxiety disorder in DSM-IV (DSM-IV 1994) due to symptoms of anxiety and the potential panic attacks that are associated with the phobia. Classical symptoms of blood and injection phobia are fear and avoidance of receiving injections, an aversion to seeing blood, and fear of having a blood sample taken (Hamilton 1995) . There is a high probability that the person will faint or be sick when the phobic situation encountered offers no possibility to escape or to avoid the stimuli (Olatunji et al. 2006 ). Blood and injection phobia is a common specific phobia with a prevalence of 7% among pregnant women (Lilliecreutz and Josefsson 2008) . Its etiology is most likely a combination of genetic factors and conditioning experiences (Davey et al. 1993; Menzies and Clark 1995) .
The hypothalamic-pituitary-adrenocortical axis in pregnancy
The hypothalamic-pituitary-adrenocortical (HPA) axis controls a distinctive diurnal pattern of cortisol output. The cortisol awakening response (CAR) seems to be under a separate central control (Fries et al. 2008) , and there is a substantial increase in cortisol secretion after the moment of awakening (Clow et al. 2004) . There is normally a decrease throughout the day, reaching its nadir in late evening. The individual diurnal rhythm of cortisol is normally maintained during pregnancy (de Weerth and Buitelaar 2005) .
During pregnancy, there is an increased stimulation of cortisol output due to the production of corticotrophinreleasing factor (CRF) produced by the placenta (Kammerer et al. 2006) . There is usually a rapid return to non-pregnant levels after delivery, but the normalization of the functions of the HPA axis can, however, sometimes take weeks (Mastorakos and Ilias 2003) .
Bioavailable cortisol remains at non-pregnant levels until around the 25th week of gestation , and the maternal HPA axis becomes hyporesponsive to stress as gestation increases (Kammerer et al. 2002; Schulte et al. 1990) .
Different patterns of derangement of the HPA axis regulation have been shown during situations of chronic or prolonged stress and maternal antenatal anxiety, and have also been associated with different psychopathologies Gold and Chrousos 2002; Kammerer et al. 2006; Nater et al. 2008; Obel et al. 2005; Roberts et al. 2004; Sarkar et al. 2006; Taylor et al. 2009; Wessa et al. 2006) .
The diurnal rhythm and/or the levels of cortisol are important indicators of the influence of the maternal psychological functioning of the HPA axis. There is support in the literature that excess of glucocorticoids during fetal development exerts multiple adverse effects. These include malformation of parts of the brain (e.g., the cerebellum), increased activity of the HPA axis in adult life, and increased likelihood of corticoid-sensitive disorders such as hypertension, increased anxiety, and exaggerated stress responses (Emack et al. 2008; Herbert et al. 2006) . Rodent studies have shown that maternal prenatal stress can affect the function of the placenta, including the expression and activity of 11 beta-hydroxysteroid dehydrogenase 2 (11β-HSD2) (Mairesse et al. 2007; Welberg et al. 2005) . This enzyme metabolizes cortisol to the inactive cortisone in the placenta and thus regulates maternal to fetal transfer. Low levels of 11β-HSD2 in the placenta have been associated with intrauterine growth restriction, possibly due to increased fetal exposure to cortisol (Dy et al. 2008; Kajantie et al. 2003; Mc Ternan et al. 2001) .
Corticosteroids act on the neurons in the brain either as a result of binding to two categories of cytoplasmic steroid receptors or by interaction with membrane-bound receptors that mediate the actions of neurotransmitters such as gamma-aminobutyricacid or glutamate. The cytoplasmic receptors have different distributions in the brain and different affinities for glucocorticoids. Salaria et al. (2006) showed in an in vitro model using microarray analysis on human fetal brain aggregates that increased cortisol exposure affects the expression of over a thousand genes.
Cortisol is present in saliva mainly in a non-protein form, representing the free, biologically active fraction (5-10%) of the total plasma cortisol concentration. It has been suggested that salivary cortisol assesses the HPA function more appropriately than serum cortisol since cortisol in the saliva reflects the biologically active hormone (Kirschbaum and Hellhammer 1994) .
Several studies on stress and anxiety during pregnancy have described higher plasma corticotrophin-releasing factor (CRF), adrenocorticotropic hormone (ACTH), and cortisol concentrations, particularly if the stress was of chronic rather than episodic nature (Demyttenaere et al. 1989; Wadhwa et al. 1996; Hobel et al. 1999) . Gestational stress does not only activate the maternal HPA axis but can also cause an increase in the release of CRF from the placenta by catecholamines and cortisol (Petraglia et al. 1996) . Another study by Petraglia found no relationship between psychosocial stress and CRF in gestational week 28 (Petraglia et al. 2001 ). On the other hand, Sarkar et al. showed that maternal state anxiety in women awaiting amniocentesis is positively correlated with plasma cortisol independent of gestation and the time of collection (Sarkar et al. 2006) .
To our knowledge, there are no studies investigating the diurnal rhythm of cortisol in an anxiety disorder such as specific phobia. The current study was therefore designed to investigate whether pregnant women suffering from blood and injection phobia have higher levels and different patterns of diurnal cortisol compared with pregnant controls.
The second aim was to investigate whether the morning values of CRF, ACTH, and serum cortisol in gestational week 25 were higher among pregnant women with blood and injection phobia compared with the controls.
Methods

Setting and participants
In 2005, 1,606 pregnant women consequently registered at the antenatal care clinics in the southeast health district in Sweden were asked to complete the Injection Phobia ScaleAnxiety (IPSA) (Öst et al. 1992 ) assessing phobic symptoms. The scale consists of 18 items describing various injection situations. The women rate the degree of anxiety in situations involving injections from 0-4 (min 0-max 72). Some examples of items included in the scale are: "Giving a blood sample by having a finger pricked," "Having a shot in the upper arm," and "Having a vein puncture." The internal consistency of the scale has been found reliable (Cronbach's α=0.86) (Öst et al. 1992) . Amongst the participants, 4.8% declined participation. Three hundred forty-seven women scored ≥20 on the Injection Phobia Scale-Anxiety and were interviewed through telephone by one authorized psychotherapist. One hundred ten women fulfilled the criteria for blood and injection phobia according to the DSM-IV and were invited to take part in the study, together with a randomly stratified sample of 110 women who scored <20 on the IPSA. The randomization was done by a research assistant who, from a data sheet, randomly picked one control woman for each index woman among the feasible group of women considering age and parity. The exclusion criterion for all subjects was inability to understand Swedish. The IPSA has a sensitivity of approximately 100% at a threshold 20 for blood and injection phobia (Lilliecreutz and Josefsson 2008) . In order to verify that women scoring <20 on the IPSA do not suffer from blood and injection phobia, 25 women randomly chosen in that particular group were interviewed through telephone by the same psychotherapist; none fulfilled the criteria according to the DSM-IV for blood and injection phobia (Lilliecreutz and Josefsson 2008) . All data about the study population were registered in the standardized Swedish antenatal records and are thus prospectively collected. The data were extracted from the records by the first author. The following data were collected to receive information concerning potential confounding variables: age, parity, marital status, occupation, or smoking. Any history, both past and current, of psychiatric disorder (depression, anxiety disorder except blood and injection phobia, eating disorder, and psychotic disease); actual chronic medical diseases (e.g., asthma with continuous need of pharmacological treatment, epilepsy, hypertension, rheumatic arthritis, inflammatory bowel disease, and diabetes); or use of antidepressants were recorded. Table 1 presents the characteristics of the study population.
Study design
In total, 220 pregnant women were included in the study, 110 in the phobia group and 110 controls. The study was supervised by each woman's midwife at the antenatal care clinic who administered the instructions for home saliva collection together with the material to the woman in the designated gestational week. The women were asked to provide morning and evening samples for the measurement of salivary cortisol in pregnancy weeks 25 and 36 as we wanted to measure the sensitivity for stress and anxiety on the HPA axis both in mid-and late pregnancy. Samples were collected immediately upon awakening and in the evening before going to bed. They were instructed not to brush their teeth, nor eat, nor drink for at least 30 min before collecting the samples. Sample collection was preferably done on ordinary days to avoid extra psychological or physical stress. The use of filter strips for saliva collection and their validation have been described in detail previously (Neu et al. 2007 ). Salivary samples were collected in Salivette test tubes (Sarstedt, Nuembrecht, Germany) and stored at −20°C. A commercial enzyme immunoassay (Salimetrics, http://www.salimetrics.com) designed for the analysis of salivary cortisol was used. The lowest concentration of cortisol that can be distinguished from 0 was <0.083 nmol/L. In week 25, when the mandatory blood sample for blood testing was taken, a sample for serum cortisol was collected. In addition, blood was drawn for the analysis of CRF and ACTH in women living close to the laboratory (n=38 women with blood and injection phobia, n=28 controls). Blood samples were drawn from a superficial cubital vein using the closed Vacutainer system and serum collected for the measurement of cortisol, ACTH, and CRF. Cortisol was measured using a chemiluminescence kit from Siemens Medical Solutions Diagnostics on an Advia Centaur XP. The lowest detectable concentration was 5.5 nmol/L. ACTH was measured using a chemiluminescence kit from Siemens Medical Solutions Diagnostics on an Immunlite 2500 Immuno Chemistry System. The lowest detectable concentration was 5 ng/L. CRF was measured using a competitive radioimmunoassay in plasma extracted on C 18 reversedphase columns. CRF antiserum B3-23 against human CRF (http://www.eurodiagnostica.com) and 125 I-CRF-Tyr o -CRF (http://www.eurodiagnostica.com) were used as antiserum and radioligand, respectively. Human CRF SC060 (http:// www.neomps.com) was used as a calibrator. The lowest detectable concentration was 5 pmol/L.
Statistical methods
All statistical analyses were performed using SPSS (version 17, Chicago, IL, USA). Wilcoxon's-non parametric test for independent variables was used when calculating for differences between serum cortisol, ACTH, and CRF between groups. Medians are used to show central tendency and interquartile range illustrates variation.
The salivary cortisol measurements were not normally distributed. Hence, all measurements were transformed by natural logarithms in order to achieve normality, which was verified using the Kolmogorov-Smirnov test. All further parametric inferential statistics were performed on these transformed variables. Dixon test for outliers confirmed the exclusion of two morning values in the control group: one in week 25 (43.6 nmol/L) and one in week 36 (49.7 nmol/L).
Repeated measures ANOVA with measurements of cortisol levels at different occasions as the within-subject factor and phobic status, gestational week, age, and parity as between-subject factors were performed in order to detect within-group as well as between-group differences over time.
Pearson's correlation was used both to explore the magnitude and direction of the linear relationship between morning salivary cortisol levels and birth weight and between morning salivary cortisol and serum cortisol in gestational week 25.
Ethics
The study protocol was approved by the ethics committee of the University Hospital in Linköping, Sweden.
Results
The individuals in the study population who had both morning and evening cortisol values either in one or both weeks were included in the analysis of salivary cortisol. In a repeated measurement, ANOVA with cortisol levels at different occasions as the within-subject factor and age, parity, gestational week, and phobic status as betweensubject factors, women with blood and injection phobia had higher levels of cortisol compared with the healthy controls (F=6.25, df=1, p=0.014). If smoking was included as a between-subject variable, the effect remained (F=6.26, df= 1, p=0.013). Table 2 presents the descriptive statistics and final sample sizes.
This ANOVA also showed that the cortisol levels concerning the whole study population in gestational week 36 (mean=9.1, SD=5.9) was higher compared with gestational week 25 (mean=8.3, SD=6.6, F=7.27, df=1, p=0.008). The diurnal decline in salivary cortisol was observed in both groups (F=60.48, df=1, p<0.000).
The ANOVA model also tested for interactions between cortisol levels and gestational week (F=0.211, df=1, p= 0.65), parity (F=0.80, df=1, p=0.37), and age (F=2.30, df= 2, p=0.10) between the women with blood and injection phobia and the healthy controls. However, no statistically significant interactions were found.
The nonparametric Wilcoxon's test was used to test for the differences in serum concentrations of CRF, ACTH, and cortisol in the two groups. No statistically significant differences were found (Table 3) .
There were no significant correlations between morning salivary cortisol levels (week 25: r=−0.024, p=0.82; week 36: r = −0.031, p = 0.81) and birth weight. A correlation between morning salivary cortisol and serum cortisol in gestational week 25 (r=0.208, p=0.042) was found.
Women with blood and injection phobia were overrepresented in the lower socioeconomic groups (p=0.018). The absolute numbers of individuals in the study population concerning the variables smoking and psychiatric disorder were low. Only one individual in the group with blood and injection phobia was using an antidepressant; none in the control group.
Discussion
This study shows that the pattern of the diurnal secretion of cortisol in pregnant women suffering from blood and injection phobia did not differ from that of women without the phobia. However, women with blood and injection phobia seem to have higher levels of cortisol output compared with the control group. This finding has an important clinical implication as these patients commonly present to the antenatal care clinics; studies have shown adverse obstetric and neonatal outcomes for these patients. Pregnant women with blood and injection phobia are more likely to deliver by elective cesarean section and have babies born with complications such as small for gestational age and prematurity (Lilliecreutz and Josefsson 2008; Lilliecreutz et al. 2011) .
Elevated levels of cortisol due to stress and anxiety can alter the obstetric and neonatal outcome, resulting in premature labor, shortened pregnancy length, low birth weight, and impaired fetal brain development (Copper et al. 1996; Wadhwa et al. 1993; Weinstock, 2005) .
Studies of samples from non-pregnant women have shown afternoon cortisol levels to be the most susceptible parameter influencing psychological stress (Grossi et al. 2001; Powell et al. 2002) . We were unable to confirm this finding in our study of pregnant women, indicating that pregnancy-induced resetting of the HPA axis blurs the relation between stress and cortisol levels in the evening.
The maternal HPA axis normally becomes hyporesponsive to stress as gestation progresses, and previous research has shown that maternal psychological functions only marginally impact the diurnal rhythm of cortisol in late pregnancy (Kammerer et al. 2002; Petraglia et al. 2001; Schulte et al. 1990; Urizar et al. 2004 ), which our current results corroborate.
It is likely that the HPA axis in nulliparas is more responsive than in women which have given birth at least once. It has been suggested in some studies that nulliparas have lower waking cortisol levels compared with multiparous women and that the midday cortisol levels are higher compared with multiparous women Rasheed 1993; Vleugels et al. 1986 ). On the other hand, Goedhart et al. (2010) have shown that women with higher age and parity have lower maternal cortisol levels in the morning, but that study was performed in the first trimester. We could not find any interactions in our study between cortisol levels, age, and parity.
Other psychiatric disorders have been associated with altered cortisol levels; melancholic depression is associated with raised cortisol and atypical depression with reduced cortisol output (Gold and Chrousos 2002) . Posttraumatic stress disorder, as well as chronic fatigue syndrome, has been reported to show a blunted CAR (Nater et al. 2008; Roberts et al. 2004; Wessa et al. 2006) . Postnatal depressive symptoms are associated with major changes in the function of the HPA axis after delivery, and women with these symptoms have been shown to have higher cortisol levels at waking and no increase at +30 min compared with controls (Kammerer et al. 2006; Taylor et al. 2009) .
One limitation in our study is the missing cortisol values at one or more collection points. These included failure to collect as directed, which has its roots in the patient material and study design. Nevertheless, women in the The reference values are for a non-pregnant population current study displayed the expected pattern of salivary cortisol decline across the day, and the mean salivary cortisol levels were similar to those reported by others for women in their 36th week of pregnancy Kivlighan et al. 2008; Meulenberg and Hofman 1990) and approximately 1.5 times higher than the mean values reported for non-pregnant controls. These observations confirm that women in this sample displayed moderate elevations in salivary cortisol normal for late pregnancy.
The support for an association between placental weight and birth weight is well recognized in the literature (Jansson and Powell 2007) . However, Kivlighan et al. (2008) also report an inverse association between morning cortisol levels, placental weight, and birth weight. We could not confirm this result in our study as no correlation was found between morning salivary cortisol levels and birth weight, which is in line with a recently published study by Goedhart et al. (2010) .
Amongst the strengths of the present study are the population-based design, the diagnoses based on clinical interviews instead of questionnaires, and the information available on an individual basis on most of the plausible confounding factors (age, parity, and gestational week) for the association between blood and injection phobia and a change in the levels and diurnal pattern of cortisol which were controlled for in the analyses, providing robust results. Finally, Fleshner et al. (1995) suggested that stress decreases the levels of corticotrophin-binding globulin, resulting in the increased levels of unbound cortisol; it is therefore preferable to measure cortisol in saliva and not in serum.
Earlier clinical and experimental studies have shown the detrimental effects of conditions associated with increasing cortisol concentrations in pregnancy. Our findings indicate that untreated blood and injection phobia during pregnancy increases cortisol concentrations. The women with blood and injection phobia during pregnancy therefore needs to be recognized and offered treatment without delay in early pregnancy.
